Novel genetic mutation discovered in Parkinson’s disease
Researchers have identified the first case of a patient with Parkinson's disease carrying a mutation in the ACMSD gene...
List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
Researchers have identified the first case of a patient with Parkinson's disease carrying a mutation in the ACMSD gene...
Flow cytometry has become a widely used technology in life science research. It is also essential for many pharma and biotechnology companies due to its proficiency in identifying biomarkers, developing biopharmaceuticals, and assessing the efficiency of new pharmacological protocols...
The Wellcome Trust Sanger Institute's Kim Judge explains how Next Generation Sequencing forms a crucial part of the scientist’s toolkit and makes a valuable contribution to the field of drug discovery...
Researchers have displayed structural details of amyloid structures which may answer many questions on the growth of harmful deposits...
The automated imaging and high-content imaging (HCI) markets are experiencing a widening dichotomy of users’ needs. Diverse hardware and software solutions are needed to bridge this divide...
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...
Antibody targets thought to cause the most damage in neurological disorders, creates potential for a unified treatment approach...
Researchers have developed a high-throughput technique that can determine if a chemical has the potential to activate key genes in seconds...
Researchers have used proteomics to examine proteins and peptides in saliva to accurately detect exposure to Zika virus...
11 August 2017 | By DiscoverX
In this webinar, DiscoverX Corporation discuss three negative allosteric modulators of metabotropic glutamate receptors, developed by Pfizer, which recently failed in preclinical development due to delayed type IV skin hypersensitivity observed in non-human primates...
A research team have discovered that in the Cancer Genome Atlas database the gene expression in reference samples differs from normal tissue, depending on where in the kidney the samples happen to have been taken from...
Researchers have discovered a trove of neuronal subtypes and gene regulators, using a new method they developed called snmC-seq...
Researchers have discovered a new biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs...
Researchers have used CRISPR to stop the expression of individual genes in cancer cells, by knocking out every known protein-encoding gene in the human genome...
Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs...